This foundational study underpins much of the subsequent research interest in GHK-Cu as a tissue remodelling compound
A notable proportion of participants in the higher-dose groups achieved HbA1c levels below 48 mmol/mol (6.5%) the diagnostic threshold for type 2 diabetes in the UK and some reached levels at or below 42 mmol/mol (6.0%), which falls within the range of non-diabetic hyperglycaemia as defined by UK and WHO criteria
The primary goals of treatment are restoration of facial volume, stimulation of collagen production, regenerative enhancement, and management of excess skin
Mounjaro: INN tirzepatide EPAR Product Information (EMA)
Other potential uses include conditions such as Multiple Sclerosis, Neuropathy, Chronic Fatigue Syndrome, Fibromyalgia, Metabolic Syndrome, Diabetes, and Hypertension